XT
FLNA

XTX Topco’s Filana Therapeutics FLNA Stock Holding History

XTX Topco’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$76.9K Buy
64,614
+31,311
+94% +$44.6K ﹤0.01% 3606
2026
Q1 		$56.3K Sell
33,303
-1,625
-5% -$3.35K ﹤0.01% 3285
2025
Q4 		$69.2K Sell
34,928
-53,635
-61% -$172K ﹤0.01% 2748
2025
Q3 		$258K Buy
88,563
+42,152
+91% +$96.9K 0.01% 1625
2025
Q2 		$84K Sell
46,411
-6,723
-13% -$12K ﹤0.01% 1916
2025
Q1 		$79.7K Sell
53,134
-40,279
-43% -$102K ﹤0.01% 1912
2024
Q4 		$220K Buy
+93,413
New +$1.64M 0.02% 1478
2024
Q1 		– Sell
-12,723
Closed -$286K – 2266
2023
Q4 		$286K Buy
+12,723
New +$269K 0.06% 661

Other funds holding FLNA

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

XTX Topco's FLNA Position: Q2 2026 in Review

XTX Topco increased its Filana Therapeutics (FLNA) stake by 94% in Q2 2026, buying an estimated $44.6K and bringing the position to 64,614 shares worth $76.9K. The position accounts for ﹤0.01% of the portfolio, ranked #3606.

XTX Topco first reported a position in FLNA in Q4 2023 and has held it in 8 quarters since. The position peaked at $286K in Q4 2023. 84 funds tracked by Wall St. Rank hold FLNA as of Q2 2026.

  • XTX Topco held 64,614 shares of Filana Therapeutics worth $76.9K as of Q2 2026.
  • XTX Topco bought 31,311 Filana Therapeutics shares in Q2 2026, an estimated $44.6K.
  • Filana Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3606 holding.
  • XTX Topco first reported a position in Filana Therapeutics in Q4 2023 and has held it in 8 quarters since.
  • XTX Topco's Filana Therapeutics position peaked at $286K in Q4 2023.
  • 84 funds tracked by Wall St. Rank held Filana Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.